Artykuły udostępnione publicznie: - Amanda BlackfordWięcej informacji
Niedostępne w żadnym miejscu: 6
Endoscopic ultrasound-guided fine needle aspiration improves the pre-operative diagnostic yield of solid-pseudopapillary neoplasm of the pancreas: an international multicenter …
JK Law, A Stoita, W Weaver, FC Gleeson, AM Dries, A Blackford, ...
Surgical endoscopy 28, 2592-2598, 2014
Upoważnienia: US National Institutes of Health
A pilot randomized sham-controlled trial of MC5-A scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy (CIPN)
TJ Smith, AR Razzak, AL Blackford, J Ensminger, C Saiki, ...
Journal of palliative care 35 (1), 53-58, 2020
Upoważnienia: US National Institutes of Health
Duodenal involvement is an independent prognostic factor for patients with surgically resected pancreatic ductal adenocarcinoma
M Dal Molin, AL Blackford, A Siddiqui, A Brant, C Cho, N Rezaee, J Yu, ...
Annals of surgical oncology 24, 2379-2386, 2017
Upoważnienia: US National Institutes of Health
Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?
Y Choi, KC Smith, A Shukla, AL Blackford, AC Wolff, E Thorner, KS Peairs, ...
Breast Cancer Research and Treatment 179, 415-424, 2020
Upoważnienia: Patient-Centered Outcomes Research Institute
What are survivorship care plans failing to tell men after prostate cancer treatment?
Y Choi, KC Smith, A Shukla, AL Blackford, PT Tran, KS Peairs, ...
The Prostate 81 (7), 398-406, 2021
Upoważnienia: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendations
A Chodoff, KC Smith, A Shukla, AL Blackford, N Ahuja, FM Johnston, ...
Journal of Surgical Oncology 125 (4), 678-691, 2022
Upoważnienia: Patient-Centered Outcomes Research Institute
Dostępne w jakimś miejscu: 148
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
M Sausen, RJ Leary, S Jones, J Wu, CP Reynolds, X Liu, A Blackford, ...
Nature genetics 45 (1), 12-17, 2013
Upoważnienia: US National Institutes of Health
A combination of molecular markers and clinical features improve the classification of pancreatic cysts
S Springer, Y Wang, M Dal Molin, DL Masica, Y Jiao, I Kinde, A Blackford, ...
Gastroenterology 149 (6), 1501-1510, 2015
Upoważnienia: US National Institutes of Health, Government of Italy
RNAi-mediated silencing of nuclear factor erythroid-2–related factor 2 gene expression in non–small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
A Singh, S Boldin-Adamsky, RK Thimmulappa, SK Rath, H Ashush, ...
Cancer research 68 (19), 7975-7984, 2008
Upoważnienia: US National Institutes of Health
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer
A Blackford, OK Serrano, CL Wolfgang, G Parmigiani, S Jones, X Zhang, ...
Clinical cancer research 15 (14), 4674-4679, 2009
Upoważnienia: US National Institutes of Health
Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance
MI Canto, JA Almario, RD Schulick, CJ Yeo, A Klein, A Blackford, EJ Shin, ...
Gastroenterology 155 (3), 740-751. e2, 2018
Upoważnienia: US National Institutes of Health, Pancreatic Cancer Action Network, USA
PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
SP Rowe, KJ Macura, E Mena, AL Blackford, R Nadal, ES Antonarakis, ...
Molecular imaging and biology 18, 411-419, 2016
Upoważnienia: US National Institutes of Health
Common variation at 2p13. 3, 3q29, 7p13 and 17q25. 1 associated with susceptibility to pancreatic cancer
EJ Childs, E Mocci, D Campa, PM Bracci, S Gallinger, M Goggins, D Li, ...
Nature genetics 47 (8), 911-916, 2015
Upoważnienia: US National Institutes of Health, National Health and Medical Research …
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
AP Klein, BM Wolpin, HA Risch, RZ Stolzenberg-Solomon, E Mocci, ...
Nature communications 9 (1), 556, 2018
Upoważnienia: US Department of Defense, US National Institutes of Health, National Health …
Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET/CT imaging in patients with advanced melanoma
SY Cho, EJ Lipson, HJ Im, SP Rowe, EM Gonzalez, A Blackford, ...
Journal of Nuclear Medicine 58 (9), 1421-1428, 2017
Upoważnienia: US National Institutes of Health
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
J Yu, AL Blackford, M Dal Molin, CL Wolfgang, M Goggins
Gut 64 (11), 1783-1789, 2015
Upoważnienia: US National Institutes of Health, Pancreatic Cancer Action Network, USA
18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer
SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ...
Journal of Nuclear Medicine 56 (7), 1003-1010, 2015
Upoważnienia: US National Institutes of Health
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration‐resistant prostate cancer
ES Antonarakis, EI Heath, DC Smith, D Rathkopf, AL Blackford, DC Danila, ...
The oncologist 18 (2), 163-173, 2013
Upoważnienia: US National Institutes of Health
Genetic mutations associated with cigarette smoking in pancreatic cancer
A Blackford, G Parmigiani, TW Kensler, C Wolfgang, S Jones, X Zhang, ...
Cancer research 69 (8), 3681-3688, 2009
Upoważnienia: US National Institutes of Health
Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
M Dal Molin, H Matthaei, J Wu, A Blackford, M Debeljak, N Rezaee, ...
Annals of surgical oncology 20, 3802-3808, 2013
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy